Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties

Cytotherapy

Volumn 18, Issue 3, 2016, Pages 320-335

  Najar, Mehdi ^a   Raicevic, Gordana ^a   André, Thibaud ^a   Fayyad Kazan, Hussein ^a   Pieters, Karlien ^a   Bron, Dominique ^a   Toungouz, Michel ^a   Lagneaux, Laurence ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

cell characterization; foreskin; immunobiological properties; immunomodulation; MSCs; tissue isolation

Indexed keywords

5' NUCLEOTIDASE; CD14 ANTIGEN; CD19 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 10; INTERLEUKIN 11; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; SCATTER FACTOR; THY 1 ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR NANOG; TRANSFORMING GROWTH FACTOR BETA; HGF PROTEIN, HUMAN; IL11 PROTEIN, HUMAN;

ARTICLE; CELL ISOLATION; CELL SIZE; CELL STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOBIOLOGY; IMMUNOMODULATION; MALE; MESENCHYMAL STROMA CELL; PHENOTYPE; PREPUCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL SELF-RENEWAL; BIOLOGICAL THERAPY; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CYTOLOGY; METABOLISM; NEWBORN; PHYSIOLOGY; PROCEDURES;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; FORESKIN; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOMODULATION; INFANT, NEWBORN; INTERLEUKIN-11; MALE; MESENCHYMAL STROMAL CELLS;

EID: 84964319363     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2015.11.013     Document Type: Article

References (53)

1. Clark EA, Kalomoiris S, Nolta JA, Fierro FA. Concise review: MicroRNA function in multipotent mesenchymal stromal cells. Stem Cells 2014;32:1074-82.
2. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009;20:419-27.
3. Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol 2014;15:1009-16.
4. Via AG, Frizziero A, Oliva F. Biological properties of mesenchymal stem cells from different sources. Muscles LigamentsTendons J 2012;2:154-62.
5. Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, et al. Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem Cell Rev 2012;8:1188-98.
6. Rada T, Reis RL, Gomes ME. Adipose tissue-derived stem cells and their application in bone and cartilage tissue engineering. Tissue Eng Part B Rev 2009;15:113-25.
7. Kim DW, Staples M, Shinozuka K, Pantcheva P, Kang SD, Borlongan CV. Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci 2013;14:11692-712.
8. Bongso A, Fong CY. The therapeutic potential, challenges and future clinical directions of stem cells from theWharton's jelly of the human umbilical cord. Stem Cell Rev 2013;9:226-40.
9. Blanpain C, Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 2006;22:339-73.
10. Fernandes KJ, McKenzie IA, Mill P, Smith KM, Akhavan M, Barnabé-Heider F, et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 2004;6:1082-93.
11. Limbourg A, Schnabel S, Lozanovski VJ, Napp LC, Ha TC, Maetzig T, et al. Genetic reporter analysis reveals an expandable reservoir of OCT4+ cells in adult skin. Cell Regen (Lond) 2014;3:9.
12. Ashley F. Foreskins as skin grafts. Ann Surg 1937;106:252-6.
13. Zaroo MI, Sheikh BA,Wani AH, Darzi MA, Mir M, Dar H, et al. Use of preputial skin for coverage of post-burn contractures of fingers in children. Indian J Plast Surg 2011;44:68-71.
14. Bartsch G, Yoo JJ, De Coppi P, Siddiqui MM, Schuch G, Pohl HG, et al. Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev 2005;14:337-48.
15. Vaculik C, Schuster C, Bauer W, Iram N, Pfisterer K, Kramer G, et al. Human dermis harbors distinct mesenchymal stromal cell subsets. J Invest Dermatol 2012;132:563-74.
16. Huang HI, Chen SK,Wang RY, Shen CR, Cheng YC. Human foreskin fibroblast-like stromal cells can differentiate into functional hepatocytic cells. Cell Biol Int 2013;37:1308-19.
17. Bi D, Chen FG, Zhang WJ, Zhou GD, Cui L, Liu W, et al. Differentiation of human multipotent dermal fibroblasts into islet-like cell clusters. BMC Cell Biol 2010;11:46.
18. Vishnubalaji R, Manikandan M, Al-Nbaheen M, Kadalmani B, Aldahmash A, Alajez NM. In vitro differentiation of human skin-derived multipotent stromal cells into putative endothelial-like cells. BMC Dev Biol 2012;12:7.
19. Li Y, Zhao Y, Cheng Z, Zhan J, Sun X, Qian H, et al. Mesenchymal stem cell-like cells from children foreskin inhibit the growth of SGC-7901 gastric cancer cells. Exp Mol Pathol 2013;94:430-7.
20. Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit M, Janzamin E, et al. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cordWharton's jelly. InVitro Cell Dev Biol Anim 2012;48:75-83.
21. Heymer A, Jany C, Kaufmann M. Isolation of keratinocytes and fibroblasts from human foreskin by one-step enzyme incubation using liberase research grade products. Biochemica 2009;2:12-14.
22. Najar M, Rodrigues RM, Buyl K, Branson S, Vanhaecke T, Lagneaux L, et al. Proliferative and phenotypical characteristics of human adipose tissue-derived stem cells: comparison of Ficoll gradient centrifugation and red blood cell lysis buffer treatment purification methods. Cytotherapy 2014;16:1220-8.
23. Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, et al. Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration. Int Immunopharmacol 2013;15:693-702.
24. Pevsner-Fischer M, Zipori D. Environmental signals regulating mesenchymal progenitor cell growth and differentiation. In: Rajasekhar VK, Vemuri MC, editors. Regulatory networks in stem cells. NewYork: Humana Press; 2009. p. 175-84.
25. Wiendl H, Mitsdoerffer M, Schneider D, Chen L, Lochmüller H, Melms A, et al. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB J 2003;17:1892-4.
26. Najar M, Raicevic G, Id Boufker H, Stamatopoulos B, De Bruyn C, Meuleman N, et al. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Exp Hematol 2010;38:922-32.
27. Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, et al. Bone marrow mesenchymal stromal cells induce proliferative, cytokinic and molecular changes during theT cell response: the importance of the IL-10/CD210 axis. Stem Cell Rev 2015;11:442-52.
28. Meisel R, Brockers S, Heseler K, Degistirici O, Bülle H,Woite C, et al. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 2011;25:648-54.
29. Gieseke F, Schütt B, Viebahn S, Koscielniak E, Friedrich W, Handgretinger R, et al. Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. Blood 2007;110:2197-200.
30. Chinnadurai R, Copland IB, Patel SR, Galipeau J. IDOindependent suppression ofT cell effector function by IFN-γ-licensed human mesenchymal stromal cells. J Immunol 2014;192:1491-501.
31. Regateiro FS, Cobbold SP, Waldmann H. CD73 and adenosine generation in the creation of regulatory microenvironments. Clin Exp Immunol 2013;171:1-7.
32. Chabannes D, Hill M, Merieau E, Rossignol J, Brion R, Soulillou JP, et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 2007;110:3691-4.
33. Patel SR, Copland IB, Garcia MA, Metz R, Galipeau J. Human mesenchymal stromal cells suppressT-cell proliferation independent of heme oxygenase-1. Cytotherapy 2015;17:382-91.
34. English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatoryT cells. Clin Exp Immunol 2009;156:149-60.
35. Ding DC, Chou HL, Chang YH, Hung WT, Liu HW, Chu TY. Characterization of HLA-G and related immunosuppressive effects in human umbilical cord stroma derived stem cells. CellTransplant 2015 Jun 3. [Epub ahead of print].
36. Najar M, Raicevic G, Jebbawi F, De Bruyn C, Meuleman N, Bron D, et al. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions withT-lymphocytes. Immunol Lett 2012;146:50-6.
37. Kyurkchiev D, Bochev I, Ivanova-Todorova E, Mourdjeva M, Oreshkova T, Belemezova K, et al. Secretion of immunoregulatory cytokines by mesenchymal stem cells.World J Stem Cells 2014;6:552-70.
38. Hsu WT, Lin CH, Chiang BL, Jui HY, Wu KK, Lee CM. Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis. J Immunol 2013;190:2372-80.
39. Rasmusson I, Ringdén O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005;305:33-41.
40. Sioud M, Mobergslien A, Boudabous A, Fløisand Y. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. Int J Oncol 2011;38:385-90.
41. Nasef A, Mazurier C, Bouchet S, François S, Chapel A, Thierry D, et al. Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol 2008;253:16-22.
42. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-43.
43. Nasef A, Chapel A, Mazurier C, Bouchet S, Lopez M, Mathieu N, et al. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr 2007;13:217-26.
44. Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Schäfer R. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med 2013;146.
45. Putoczki T, Ernst M. More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer. J Leukoc Biol 2010;88:1109-17.
46. Hjertner O, Torgersen ML, Seidel C, Hjorth-Hansen H, Waage A, Børset M, et al. Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease. Blood 1999;94:3883-8.
47. Goff JP, Shields DS, Petersen BE, Zajac VF, Michalopoulos GK, Greenberger JS. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression. Stem Cells 1996;14:592-602.
48. Amorin B, Alegretti AP, Valim V, Pezzi A, Laureano AM, da Silva MA, et al. Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. Hum Cell 2014;27:137-50.
49. Auletta JJ, Eid SK, Wuttisarnwattana P, Silva I, Metheny L, Keller MD, et al. Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation. Stem Cells 2015;33:601-14.
50. Hill GR, Cooke KR, Teshima T, Crawford JM, Keith JC Jr, Brinson YS, et al. Interleukin-11 promotesT cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J Clin Invest 1998;102: 115-23.
51. Teshima T, Hill GR, Pan L, Brinson YS, van den Brink MR, Cooke KR, et al. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. J Clin Invest 1999;104:317-25.
52. Kizil C, Kyritsis N, Brand M. Effects of inflammation on stem cells: together they strive? EMBO Rep 2015;16:416-26.
53. Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, et al. The source of human mesenchymal stromal cells influences theirTLR profile as well as their functional properties. Cell Immunol 2011;270:207-16.